Clinical Trial Update: Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial [Phase 4]

View source ↗

Summary

This Phase 4, investigator-blinded, controlled, randomized trial in obese patients with severe chronic plaque psoriasis found that moderate weight loss enables …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Plaque Psoriasis

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: Universita di Verona | Conditions: Chronic Plaque Psoriasis, Obesity | Phase 4 | Status: COMPLETED